The Government Accountability Office today recommended certain actions to enhance federal efforts to monitor and address antibiotic resistance.

Among other actions, GAO said the Centers for Disease Control and Prevention should develop a plan for timely reporting of antibiotic resistance in priority pathogens, and the Department of Health and Human Services should develop a strategic framework to incentivize development of new treatments for antibiotic-resistant infections. It also said the Combating Antibiotic-Resistant Bacteria Task Force should include in its annual updates to the president plans to address barriers to fully implementing the National Action Plan for Combating Antibiotic-Resistant Bacteria.

The Senate Health, Education, Labor and Pensions and House Energy and Commerce committees requested the report.

Headline
The deadline to apply for the inaugural AHA Age-Friendly Healthcare Impact Award is Sept. 25. The award, created by the AHA and The John A. Hartford Foundation…
Headline
The Substance Abuse and Mental Health Services Administration announced Sept. 18 that it awarded $42.3 million in grants to states and territories to support…
Headline
There are now 17,180 confirmed cases of cyclosporiasis in the U.S., the Centers for Disease Control and Prevention reported Aug. 25. At least 11,844 additional…
Headline
The Food and Drug Administration has approved a blood test for detecting Alzheimer’s by Roche and Eli Lilly, according to an announcement Aug. 24 by Roche. The…
Headline
There have been 15,716 confirmed cases of cyclosporiasis across 47 states, Washington, D.C., and Puerto Rico since May 1, the Centers for Disease Control and…
Blog
By Rani E. Snyder, President, The John A. Hartford Foundation and Dr. Chris DeRienzo, AHA Chief Physician Executive/President of AHA’s HRET As the U.S.…